Frequency of CYP2C9 (*2, *3 and IVS8‑109A>T) allelic variants, and their clinical implications, among Mexican patients with diabetes mellitus type 2 undergoing treatment with glibenclamide and metformin
2019 ◽
Vol 14
(1)
◽
pp. 15-21
2016 ◽
Vol 55
(3)
◽
pp. 179-184
◽